Masoabi Sefojane: The Cost of a 35-Year Diagnosis Delay
Masoabi Sefojane, Geographic Expansion Lead, Africa and Asia Pacific at MicroHealth , shared a post on LinkedIn:
“The Cost of a 35-Year Diagnosis Delay
A child waits 35 years for diagnosis.
Not weeks.
Not months.
Three and a half decades.
During that time: untreated bleeds.
Preventable joint damage.
Chronic pain.
Opportunities gone.
The World Bleeding Disorders Registry tracked data from 40 countries.
The pattern is unmistakable: diagnosis in low-middle-income countries lags up to 4 decades behind high-income countries.
But statistics don’t capture this cost.
Without early prophylaxis, haemophilic arthropathy develops by age 20.
Permanent joint damage.
The 3-hour journeys to the nearest centre.
The surgeries that follow.
The professional opportunities lost to disability.
By age 30-40, this damage is irreversible.
In South Africa alone, treating a single severe haemophilia patient on demand costs over R1.29 million per year. Prophylaxis costs R949,000. That R342,000 annual difference per patient compounds across a lifetime, before a single surgery, physiotherapy session, or lost wage is counted. The modelling doesn’t even include the cost of long-term complications, disability, or mortality.
In sub-Saharan Africa, 36.5% of patients over 20 have musculoskeletal damage. 39% have no professional activities.
Call it what it is: late diagnosis creates preventable disability.
Here’s the cruel part: we know how to prevent this.
Primary prophylaxis before age 3 prevents joint damage almost entirely.
So the gap isn’t clinical knowledge.
The gap is systems.
We have knowledge.
We don’t have coordination.
If we could prevent 95% of this damage with early diagnosis, why are our systems only finding 37% of patients?”

Stay updated with Hemostasis Today.
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored
-
Jun 24, 2026, 17:04Recurrent Cervical Internal Carotid Vasospasm Linked to Autosomal Recessive PTGIS Defect – International Journal of Stroke
-
Jun 24, 2026, 16:49Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc